84 related articles for article (PubMed ID: 16103583)
1. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population.
Tran TM; Oliveira-Ferreira J; Moreno A; Santos F; Yazdani SS; Chitnis CE; Altman JD; Meyer EV; Barnwell JW; Galinski MR
Am J Trop Med Hyg; 2005 Aug; 73(2):244-55. PubMed ID: 16103583
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of naturally acquired immune responses against novel pre-erythrocytic Plasmodium vivax proteins in a low endemic malaria population located in the Peruvian Amazon Basin.
Ventocilla JA; Tapia LL; Ponce R; Franco A; Leelawong M; Aguiar JC; Baldeviano GC; Wilder BK
Malar J; 2024 May; 23(1):163. PubMed ID: 38783317
[TBL] [Abstract][Full Text] [Related]
3. The Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian Amazon.
de Sousa TN; Kano FS; de Brito CF; Carvalho LH
Mem Inst Oswaldo Cruz; 2014 Aug; 109(5):608-17. PubMed ID: 25185002
[TBL] [Abstract][Full Text] [Related]
4. Anti-Plasmodium vivax merozoite surface protein 3 ϒ (PvMSP3 ϒ) antibodies upon natural infection.
Kuamsab N; Putaporntip C; Kakino A; Kosuwin R; Songsaigath S; Tachibana H; Jongwutiwes S
Sci Rep; 2024 Apr; 14(1):9595. PubMed ID: 38671033
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the acquired immune responses to Plasmodium vivax VIR variant antigens in individuals living in malaria-endemic areas of Brazil.
Oliveira TR; Fernandez-Becerra C; Jimenez MC; Del Portillo HA; Soares IS
Malar J; 2006 Oct; 5():83. PubMed ID: 17026752
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against
Arévalo-Herrera M; Miura K; Cespedes N; Echeverry C; Solano E; Castellanos A; Ramirez JS; Miranda A; Kajava AV; Long C; Corradin G; Herrera S
Front Immunol; 2021; 12():634738. PubMed ID: 34248932
[TBL] [Abstract][Full Text] [Related]
7. Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein.
Watson QD; Carias LL; Malachin A; Redinger KR; Bosch J; Bardelli M; Baldor L; Feufack-Donfack LB; Popovici J; Moon RW; Draper SJ; Zimmerman PA; King CL
Malar J; 2023 Dec; 22(1):369. PubMed ID: 38049801
[TBL] [Abstract][Full Text] [Related]
8. The Blood Stage Antigen RBP2-P1 of Plasmodium vivax Binds Reticulocytes and Is a Target of Naturally Acquired Immunity.
Chim-Ong A; Surit T; Chainarin S; Roobsoong W; Sattabongkot J; Cui L; Nguitragool W
Infect Immun; 2020 Mar; 88(4):. PubMed ID: 32014895
[TBL] [Abstract][Full Text] [Related]
9. Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity.
Han JH; Cho JS; Ong JJY; Park JH; Nyunt MH; Sutanto E; Trimarsanto H; Petros B; Aseffa A; Getachew S; Sriprawat K; Anstey NM; Grigg MJ; Barber BE; William T; Qi G; Liu Y; Pearson RD; Auburn S; Price RN; Nosten F; Rénia L; Russell B; Han ET
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008202. PubMed ID: 32645098
[TBL] [Abstract][Full Text] [Related]
10. Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein.
Michon P; Fraser T; Adams JH
Infect Immun; 2000 Jun; 68(6):3164-71. PubMed ID: 10816459
[TBL] [Abstract][Full Text] [Related]
11. Multiplexed Microsphere-Based Flow Cytometric Assay to Assess Strain Transcending Antibodies to
Alves JRS; de Araújo FF; Pires CV; Teixeira-Carvalho A; Lima BAS; Torres LM; Ntumngia FB; Adams JH; Kano FS; Carvalho LH
Front Immunol; 2021; 12():704653. PubMed ID: 34675915
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal analysis of antibody responses to Plasmodium vivax sporozoite antigens following natural infection.
Thawornpan P; Nicholas J; Malee C; Kochayoo P; Wangriatisak K; Tianpothong P; Ntumngia FB; J Barnes S; H Adams J; Chootong P
PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011907. PubMed ID: 38277340
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and distribution of Plasmodium vivax Duffy Binding Protein gene duplications in Sudan.
Ahmed S; Pestana K; Ford A; Elfaki M; Gamil E; Elamin AF; Hamad SO; Elfaki TM; Abukashawa SMA; Lo E; Abdel Hamid MM
PLoS One; 2023; 18(7):e0287668. PubMed ID: 37471337
[TBL] [Abstract][Full Text] [Related]
14. Naturally acquired antibodies against Plasmodium vivax pre-erythrocytic stage vaccine antigens inhibit sporozoite invasion of human hepatocytes in vitro.
Ntumngia FB; Kolli SK; Annamalai Subramani P; Barnes SJ; Nicholas J; Ogbondah MM; Barnes BB; Salinas ND; Thawornpan P; Tolia NH; Chootong P; Adams JH
Sci Rep; 2024 Jan; 14(1):1260. PubMed ID: 38218737
[TBL] [Abstract][Full Text] [Related]
15. A comparison of non-magnetic and magnetic beads for measuring IgG antibodies against Plasmodium vivax antigens in a multiplexed bead-based assay using Luminex technology (Bio-Plex 200 or MAGPIX).
Mazhari R; Brewster J; Fong R; Bourke C; Liu ZSJ; Takashima E; Tsuboi T; Tham WH; Harbers M; Chitnis C; Healer J; Ome-Kaius M; Sattabongkot J; Kazura J; Robinson LJ; King C; Mueller I; Longley RJ
PLoS One; 2020; 15(12):e0238010. PubMed ID: 33275613
[TBL] [Abstract][Full Text] [Related]
16. IgM antibody responses against
de Assis GMP; de Alvarenga DAM; Souza LBE; Sánchez-Arcila JC; Silva EFE; de Pina-Costa A; Gonçalves GHP; Souza JCJ; Nunes AJD; Pissinatti A; Moreira SB; Torres LM; Costa HL; Tinoco HDP; Pereira VDS; Soares IDS; de Sousa TN; Ntumngia FB; Adams JH; Kano FS; Hirano ZMB; Pratt-Riccio LR; Daniel-Ribeiro CT; Ferreira JO; Carvalho LH; Alves de Brito CF
Front Cell Infect Microbiol; 2023; 13():1169552. PubMed ID: 37829607
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans.
Martinez FJ; Guillotte-Blisnick M; Huon C; England P; Popovici J; Laude H; Arowas L; Ungeheuer MN; Reimer JM; Carter D; Reed S; Mukherjee P; Chauhan VS; Chitnis CE
Sci Rep; 2023 Aug; 13(1):13904. PubMed ID: 37626150
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts.
Rosado J; White MT; Longley RJ; Lacerda M; Monteiro W; Brewster J; Sattabongkot J; Guzman-Guzman M; Llanos-Cuentas A; Vinetz JM; Gamboa D; Mueller I
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009165. PubMed ID: 33591976
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal IgG antibody responses to Plasmodium vivax blood-stage antigens during and after acute vivax malaria in individuals living in the Brazilian Amazon.
Tashi T; Upadhye A; Kundu P; Wu C; Menant S; Soares RR; Ferreira MU; Longley RJ; Mueller I; Hoang QQ; Tham WH; Rayner JC; Scopel KK; Lima-Junior JC; Tran TM
PLoS Negl Trop Dis; 2022 Nov; 16(11):e0010773. PubMed ID: 36417454
[TBL] [Abstract][Full Text] [Related]
20. Impact of Plasmodium vivax malaria on executive and cognitive functions in elderlies in the Brazilian Amazon.
Pessoa RC; Oliveira-Pessoa GF; Souza BKA; Sampaio VS; Pinto ALCB; Barboza LL; Mouta GS; Silva EL; Melo GC; Monteiro WM; Silva-Filho JH; Lacerda MVG; Baía-da-Silva DC
Sci Rep; 2022 Jun; 12(1):10361. PubMed ID: 35725784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
